The healthcare provider posted an 18% revenue jump year-on-year, but profitability collapsed, turning a net profit into a loss.
Aster DM Quality Care reported robust revenue growth for Q1 FY27, but a sharp drop in profitability led to a quarterly loss, marking a significant reversal from the previous year.
Aster DM Quality Care delivered a quarter of stark contrasts. While revenue grew healthily, profitability collapsed, swinging the company into a net loss for Q1 FY27. This marks a sharp reversal from the profit earned in the same period last year.
The company's revenue reached ₹725.7 crore, a solid 18.4% increase compared to Q1 FY26. Sequentially, revenue also grew by 10.8% from the March quarter. However, profit fell to a loss of ₹14.3 crore, a dramatic 117.7% decline year-on-year and a 152.1% drop from the previous quarter. This pushed the net profit margin down to -2.0%, a steep 1,510 basis point contraction from the 13.1% margin seen a year ago.
The recent quarterly trend shows a clear divergence between top-line strength and bottom-line pressure.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Period | Quarter ended June 2026 | Quarter ended March 2026 | Quarter ended June 2025 |
| Revenue (₹ Cr) | 725.73YoY +18% | 655.10 | 613.04 |
| Profit (₹ Cr) | -14.3YoY -118% | 27.46 | 80.59 |
| Net Profit Margin (%) | -2.0YoY -115% | 4.2 | 13.1 |
Key Points
Despite the quarterly setback, Aster DM's valuation remains at a significant discount to the industry, trading at a P/E of 4.5. The immediate challenge is to translate its consistent revenue momentum back into sustainable profitability.
Live Chart
· ASTERDM
(BSE)
ISIN: INE914M01019
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.